EPIGRAL — From Chlor-Alkali to Specialty Chemicals Multibaggar 1️⃣ EPIGRAL — From Chlor-Alkali to Specialty Chemicals
Business Profile:
Epigral is transforming from a predominantly commodity Chlor-Alkali manufacturer into an integrated, derivative-led specialty chemical platform.
Key Fundamental + Concall Takeaways:
🎯 Target business mix: 70:30 in favour of Derivatives & Specialty Chemicals
Captive chlorine consumption increased from 72% → 75%
Epichlorohydrin capacity doubling: 50,000 → 1,00,000 TPA
CPVC resin capacity doubling: 75,000 → 1,50,000 TPA
New 1,25,000 TPA Epoxy Resin & Formulations plant approved
Epoxy + Multi-Purpose Plant commissioning targeted for H2FY28
FY26 EBITDA margin remained above 17% in every quarter
ROCE around 16%
Net Debt/Equity only 0.2x
Chlorotoluene is still awaiting customer approvals and has not yet contributed meaningfully to profits
My View:
The important part is the change in earnings mix. If derivatives and specialty products increasingly replace commodity Chlor-Alkali earnings, the business could command a better quality/multiple over time.
Epigral Ltd
No trades
No trades
In-depth trading ideas
EPIGRAL - BreakoutEpigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals in India. Epigral’s Dahej facility is a backward and forward integrated and automated complex with a well-planned infrastructure.
In India, Epigral is the first to set up an Epichlorohydrin plant and largest capacity plant of CPVC Resin. Epigral is also a leading manufacturer of Caustic Soda, Caustic Potash, Chloromethanes, Hydrogen Peroxide, Chlorine and Hydrogen.
Breakout from the Triangle pattern
Market Cap: ₹ 8,996 Cr.
Promoter holding: 68.8 %
FII holding: 3.06 %
DII holding: 4.78 %
Public holding: 23.3 %
Debt: ₹ 593 Cr.
Debt 3Years back: ₹ 993 Cr.
Epigral Ltd for 30%+ gains; Strong Q2 resultsDate: 10 Nov’24
Symbol: EPIGRAL
Timeframe: Daily
Epigral (formerly known as Meghmani Finechem) seems to be in Wave V of 3 which is heading towards 2800 (33% from current price of 2100) as seen in the chart. There is a possibility of Wave V extending to 3000 which we can assess once it closes above 2500. Let’s keep a stop loss at 1840 on closing basis. Q2FY25 results on Saturday were good so the run up should continue.
This is not a trade recommendation. Please do your own analysis. And I have the right to be wrong.
Epigral (jise pehle Meghmani Finechem ke naam se jaana jaata tha) 3 ke Wave V mein hai aisa lagta hai jo 2800 (2100 kee vartamaan keemat se 33%) ki taraf badh raha hai jaisa ki chart mein dekha gaya hai. Wave V ke 3000 tak badhane ki sambhaavana hai jiska aakalan hum 2500 se upar band hone par kar sakte hain. 1840 ke neeche closing basis stop loss rakhein. Shanivaar ko Q2FY25 ke nateeje achhe rahe to teji jaari rehni chahiye.
Yah koi trade lene ki salah nahin hai. Kripya apana vishleshan khud karein. Aur mujhe galat hone ka adhikaar hai.
Fourth largest manufacturer of Chlor-Alkali has given breakoutHello Everyone, i hope you all will be doing good in your trading and your life as well, i have brought another stock from chemical sector which produces Chloralkalis: Caustic Soda Lye and Flakes, Liquid Chlorine, Hydrogen, Caustic Potash Lye and Flakes, etc. Company belongs from solid fundamentally Meghami Group. it is the fourth largest manufacturer of Chlor-Alkali in India.
Stock has already given breakout of Triangle Pattern on weekly timeframe and after retesting the breakout level stock has given breakout of neckline of previous highs. Now there is high probability stock should fly from here towards our given targets on charts. Stock is good to hold for long term also, this can give you multifolds returns in long term. For short term and near long term targets i have already placed on chart.
Market Cap
₹ 5,092 Cr.
Current Price
₹ 1,226
High / Low
₹ 1,277 / 811
Stock P/E
26.0
Book Value
₹ 272
Dividend Yield
0.41 %
ROCE
32.1 %
ROE
39.4 %
Face Value
₹ 10.0
Industry PE
18.6
Debt
₹ 971 Cr.
EPS
₹ 47.2
Promoter holding
71.4 %
Intrinsic Value
₹ 1,483
Pledged percentage
0.00 %
EVEBITDA
12.4
Change in Prom Hold
0.00 %
Profit Var 5Yrs
18.3 %
Sales growth 5Years
29.6 %
Return over 5years
%
Debt to equity
0.86
Net profit
₹ 196 Cr.
ROE 5Yr
37.7 %
Profit growth
-47.8 %
PROS:-
Company has delivered good profit growth of 18.3% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 36.8%
Debtor days have improved from 46.8 to 27.7 days.
CONS:-
Company might be capitalizing the interest cost.
Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades.
Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's.
Thankyou.
Call and put stratagyMoving Averages (MA): The script uses two simple moving averages (SMA) — a shorter one (default length of 9) and a longer one (default length of 21). The strategy is based on the crossover of these MAs.
RSI (Relative Strength Index): An RSI indicator is used to check if the asset is overbought or oversold, adding another layer of confirmation for buy or sell signals.
Buy Signal: A buy signal is generated when the shorter MA crosses above the longer MA, and the RSI is below the oversold level (30).
Sell Signal: A sell signal is triggered when the shorter MA crosses below the longer MA, and the RSI is above the overbought level (70).
How to Use:
Copy and paste the script into the Pine Script editor in TradingView.
Adjust the input parameters as needed based on backtesting results or personal preferences.
Add the indicator to your chart and analyze its performance.
Important Note:
Backtest the strategy with historical data to check its performance and make necessary adjustments.
No indicator can guarantee 90% accuracy consistently. It is crucial to use risk management techniques and combine this indicator with other market analysis tools.
Would you like to add any specific features or customize this strategy further?
BUY TODAY SELL TOMORROW for 5%DON’T HAVE TIME TO MANAGE YOUR TRADES?
- Take BTST trades at 3:25 pm every day
- Try to exit by taking 4-7% profit of each trade
- SL can also be maintained as closing below the low of the breakout candle
Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that 90% of the stocks give most of the movement in just 1-2 days and the rest of the time they either consolidate or fall
Trendline Breakout in EPIGRAL
BUY TODAY SELL TOMORROW for 5%
Epigral Ltd - Breakout Setup, Move is ON...#EPIGRAL trading above Resistance of 1736
Next Resistance is at 2545
Support is at 1235
Here are previous charts:
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
Epigral-DO NOT MISS!Logic:-RSI positive divergence near trendline support followed by Consolidation breakout
Epigral is yet another chemical stock showing reversal signs. It has got decent return ratios (ROE , ROCE above 30% ) and PE ratio of 18 at CMP.
Relatively safer stock to bet as technofundamentals are strong together.
Happy trading!
Amazing breakout on Weekly / Daily Timeframe - EPIGRALCheckout an amazing breakout happened in the stock in Weekly timeframe, macroscopically seen in Daily timeframe. Having a great favour that the stock might be bullish expecting a staggering returns of minimum 25% TGT. IMPORTANT BREAKOUT LEVELS ARE ALWAYS RESPEECTED!
NOTE for learners: Place the breakout levels as per the chart shared and track it yourself to get amazed!!
#No complicated chart patterns
#No big big indicators
#No Excel sheet or number magics
TRADE IDEA: WAIT FOR THE STOCK TO BREAKOUT IN LOWER TIMEFRAME AND RETRACE IF NEEDED. SL IS NEARER SUPPORT ZONE IN Daily TIMEFRAME.
PS: No new Nifty500 script can escape from me when making a breakout. :-)
PS: This script is shared 1-2 days delayed. Sorry for the delayed charts.
EPIGRAL - Swing Trade - 18th February #stocksEPIGRAL (1W TF) - Swing Trade Analysis given on 18th Feb, 2024
Pattern: SYMMETRICAL TRIANGLE
- Volume buildup at Resistance - Done ✓
- Resistance Breakout - In Progress
- Retest & Consolidation - In Progress
#stocks #swingtrade #chartanalysis #priceaction #traderyte #EPIGRAL #stockmarket #sharemarket #viral #sharemarketindia #StockMarketindia
EPIRGRAL LTD / Meghmani Finechem LimitedEpigral is India's 4th largest manufacturer of Caustic Soda, Chlorine and Hydrogen and a leading manufacturer of Caustic Potash, Chloromethanes and Hydrogen Peroxide.
Epigral is strengthening its position in the specialty chemical segment by expanding CPVC Resin capacity to 75,000 TPA, setting up CPVC compound capacity of 35,000 TPA, entering into the Chlorotoluene & value chain and setting up R & D centre.
The company said it has launched first research and development centre at Ahmedabad spread over 14,374 square metres with an initial investment of Rs 30 crore.
PE is attractive at 18.17, lower than its sector PE ratio of 104.49.
Annual Revenue rose 41.24%, in the last year to Rs 2,196.38 Crores. Its sector's average revenue growth for the last fiscal year was 16.95%.
Annual Net Profit rose 39.76% in the last year to Rs 353.29 Crores. Its sector's average net profit growth for the last fiscal year was 4.91%.
Promoter Share Holding remains same at 71.38%.
Worth holding the stock for 2-3 Years !!!
Swing Trade Buy MFLAs per Swing Trading Strategy MEGHMANI FINECHEM LIMITED Looks Bullish
Support taken near 970-980 if its break then it will test 920-930 Level
Positive Notes -
Prompters Holding above 71 %
Pledged Stock - 0%
Last 3 year Constant Profitable
FII and MFs are Buying this stock and increasing Participation.
Level to Be Consider
Buy Near 995-1005
Stop loss - 920
Target 1080,1120,1180
Time Frame - 90 Days
Only For Educational Purpose.






















